Both community acquired pneumonia and diabetes mellitus are common in Bangladesh. Though hospitalization of diabetic patients with CAP is increasing, data regarding their clinical presentation, microbial characteristics, antimicrobial susceptibility and outcome are lacking. This study was aimed at finding any difference in clinical presentation, bacterial causes, antimicrobial susceptibility pattern of isolated bacteria and outcome in diabetic and non-diabetic hospitalized patients with CAP. In this study total 47 diabetic and 43 non-diabetic adult hospitalized patients with CAP were enrolled. Clinical presentation of CAP differed in diabetics and non-diabetics. Frequency of atypical presentation and CURB-65 score were significantly higher in diabetics. Pleural effusion with multilobar infiltration was also common feature for CAP in diabetic patients. Klebsiella pneumoniae was the most frequent causative pathogen for CAP in diabetic patients, whereas Streptococcus pneumoniae was the most frequent causative agent for non-diabetic patients. Bacteria isolated from sputum sample of diabetic patients with CAP were resistant to almost all recommended antibiotics used for CAP but 100% of isolates were sensitive to Carbapenems. Pulmonary complications were relatively more in diabetics than in non-diabetics. Hospitalized diabetics with CAP required referral to intensive care unit more than that of non-diabetics. So, diabetic patients with CAP need extra attention.
Introduction
Community acquired pneumonia (CAP) is the lower respiratory tract infection acquired outside the hospital or long term health care facility. It is diagnosed in the community or within 48 hours of admission in the hospital 1,2 . CAP is usually acquired through droplet infection. Once organisms settle in the alveoli, an inflammatory response ensues. The classical pathological response evolves through the phases of congestion, red and grey hepatisation and finally resolution with little or no scarring. Death rates in hospital admitted patients are between 5-10% but may be as high as 50% in severe illness 3 .
Diabetes mellitus (DM) is a group of metabolic disorder characterized by a state of chronic hyperglycaemia resulting from defect in insulin secretion, insulin action or both. Its prevalence posed a serious threat to the entire population of the world 4 . In 2000 Bangladesh had 3.2 million people with diabetes 5 . Pathogenesis of the major long-term complications of DM is due to both microangiopathic process and non-enzymatic glycosylation of tissue protein. A wide range of function of neutrophil and macrophage are impaired in DM. These include chemotaxis, adherence, phagocytosis and the ability to kill the phagocytosed microorganism. Reduction in intracellular killing of microbes with free radicals superoxides and hydrogen peroxide called the respiratory burst are also impaired 6 . Disturbances in acquired immunity also occur in diabetic patients 7, 8 . Alteration in the function of capillary endothelium, the rigidity of red blood cells and changes in the oxygen dissociation curve that occur as a result of chronic hyperglycaemia may affect the hosts' ability to combat infections. As a result patients with long-term diabetes mellitus are more prone to infections than non-diabetic patients 9 . Staphylococcus aureus is the major pathogen in the aetiology of both CAP and nosocomial pneumonia in diabetic patients 14 . Other vital signs such as temperature, pulse rate were recorded accordingly. Chest X-ray was interpreted by the radiologist who was unaware of patients' clinical condition. The presence of comorbid conditions was determined by patient's reports and medical records reviews. From each patient, sputum was collected in a wide mouth container, cultured in blood agar and MacConkey's agar media at 37°C for up to 48 hours in the Microbiology Laboratory of BIRDEM Hospital. Positive growth was identified by colony characteristics and biochemical tests. Antimicrobial susceptibility pattern was determined by disc diffusion (Kirby-Bauer) method if culture was positive 15 . Standardized commercially available antibiotic discs (Sigma, Germany) of Coamoxiclav, ceftriaxone, ceftazidime, clarithromycin, levofloxacin, meropenem and imipenem were used.
Only immediate or short outcome was observed which was one of the objective of this study. Immediate outcome was defined as outcome of first setting in terms of hospital duration, improvement, referral to ICU, development of complications or mortality outcome during the hospital course. Improvement of the patient means clinical wellbeing, improvement of blood chemistry & radiological improvement. Pre-designed questionnaire (data sheet) & consent form were filled up accordingly from all the enlisted patient.
Results
Statistical analysis was conducted using SPSS version 11 for Windows software. Parametric data were expressed in mean±SD. Parametric data were evaluated by independent sample "t" test & categorical data were evaluated by Chi-squre ( 2 ) test as needed. Level of significance for all analytical test was set as 0.05 & p=≤0.05 is considered significant.
Clinico-demographic presentation:
Total 90 patients with CAP were studied over a period of 10 months. Among them 47 were diabetic and 43 were non-diabetic. Mean age (±SD) of the diabetic and non diabetic groups were 56.3 (±12.2) years and 35.7(±10.5) years respectively ( Table I) . Majority of the patients of both groups had respiratory rate ≥30/min (85.1% in diabetic group and 62.8% in non-diabetic groups). Hypotension was noted in about half of the patients of diabetic group (46.8%) but only 11.6% in non-diabetic group. On clinical examination pleural effusion was found in most of the diabetic patients (83.0%). Presence of consolidation in the lungs was higher in non-diabetic group. All these differences were statistically significant (p<0.05) ( Table I ). It was observed that diabetic patients with CAP presented with high E.S.R and BUN in comparison with nondiabetic patients with CAP whereas non-diabetic patients with CAP presented with high total count, increased temperature and higher pulse rate than that of diabetic patients with CAP Diabetic patients had significantly higher CURB-65 scoring in comparison with non-diabetic patients (P<0.05).
Comparison of Chest X-ray (CXR) revealed that unilobar infiltration was more common in nondiabetic patients with CAP whereas multilobar infiltrate was more common in diabetic patients with CAP. Pleural effusion with infiltration was more common in diabetic patients with CAP (Table II) . Table  IV . It was observed that all the 9 isolates (100%) of Streptococcus pneumoniae from non-diabetic patients with CAP were sensitive to Co-amoxiclav, Ceftriaxone, Ceftazidime, Imipenem & Meropenem but 77.8% sensitive to Clarithromycin and Levofloxacin. All the isolates (100%) of Klebsiella pneumoniae from diabetic patients with CAP were resistant to Co-amoxiclav, 66.7% to Levofloxacin, 55.6% to Clarithromycin and 11.1% to Ceftriaxone and Ceftazidime. All Klebsiella pneumoniae isolates from non-diabetic patients with CAP were sensitive to Co-amoxiclav, Ceftriaxone and Ceftazidime. All isolates of Staphylococcus aureus from diabetic patients with CAP were sensitive to Ceftriaxone, Imipenem and Meropenem and 50% sensitive to Ceftazidime, Clarithromycin and Levofloxacin and all were resistant to Coamoxiclav. E. coli were isolated from only diabetic patients. All E. coli isolates were sensitive to Ceftazidime, Imipenem and Meropenem, 50% to Ceftriaxone and Levofloxacin and all were resistant to Co-amoxiclav. All the Pseudomonas aeruginosa isolates were from diabetic patients with CAP, which were sensitive to Ceftazidime, Imipenem and Meropenem and were resistant to Co-amoxiclav, Ceftriaxone, Clarithromycin and Levofloxacin. Only one isolate of Acinetobacter was from diabetic patient and it was sensitive to Ceftazidime, Ceftriaxone, Imipenem and Meropenem and resistant to Co-amoxiclav, Clarithromycin and Levofloxxacin. More than one organism was isolated from the sputum of 7 (20%) of diabetic patient with CAP. These group of organism were 100% resistant to Co-amoxiclav, Clarithromycin, levofloxacin and 57% resistant to Ceftriaxone and Ceftazidime but all (100%) were sensitive to Meropenem and Imipenem, 42% sensitive to Ceftriaxone and Ceftazidime. Outcome was determined in terms of duration of hospital stay, improvement and mortality. Table V showed the mean duration of hospital stay of two groups of patients. It was observed that mean duration of hospital stay was higher in diabetic group than in non-diabetic group, which was statistically significant (P<0.05). 
Anti-microbial agents n= 0 n= 9 n= 9 n= 2 n= 2 n= 1 n= 2 n= 0 n= 2 n= 0 n= 1 n= 0 n= 7 n= 0 
Discussion
Many studies carried out on diabetic patients with CAP 10,11,16 , but this study included both diabetic and non-diabetic patients and revealed many interesting findings. Most of the aged diabetic patients presented with atypical pneumonia. Altered mental status and hypotension were the predominant clinical features in diabetic patients with CAP. On the other hand non-diabetic subjects presented with typical respiratory symptoms of pneumonia. This atypical presentation was significantly higher in diabetic group may be due to relatively older age in diabetic patients included in this study 3 .
A Spanish study 13 found diabetes mellitus (DM) as an independent predictor for the development of pleural effusion. Although their data support our findings but they included DM with co-morbidities in their study whereas we excluded DM with advanced nephropathy and heart failure from our study. This difference of presentation may be due to altered capillary permeability, less vigorous immune response, altered neutrophil and macrophage function of diabetic subjects than nondiabetics. Respiratory rate ≥30/min and presence of hypotension were also common in diabetic patients with CAP. Altered mental status, presence of hypotension higher respiratory rate all favoured aged diabetic patients to make high CURB-65 scoring in comparison with non-diabetic patients with CAP. Mean BUN was higher in diabetic patients. Mean ESR was also higher in diabetic subjects, whereas total count of WBC was lower in DM with CAP subjects in comparison with nondiabetics. A population based cohort study found that there was no difference of BUN and total count of WBC between diabetic and non-diabetic patients when they presented with pneumonia 16 . This data did not support our data.
In our study we could isolate organisms from 38.9% of sputum samples by culture. A study conducted in Spain 13 that included sputum culture and blood serology as a diagnostic tool could detect 42% causative pathogen from CAP patients. Other studies could isolate organisms from 46% patients having CAP. They included both diabetic and nondiabetic patients in their study. Streptococcus pneumoniae was the most frequent causative organism in both DM and non DM patients followed by Haemophilus influenzae, Staph aureus, and other atypical organism like Chlamydia 17,18 . Our findings differ from their study in terms of etiological diagnosis of CAP. The etiology of CAP depends on the geographic areas, the study population and the utilized microbiological lab test 17 . Some important microbiological characteristics came out when we compared two groups of subjects.
Klebsiella pneumoniae was the most frequent isolated organism for the diabetic patients on the other hand Streptococcus pneumoniae was the commonest bacteria causing CAP in non-diabetic subjects. Other bacteria found were Staphylococcus aureus, E. coli and Pseudomonas aeruginosa. More than one organism was also isolated. Most of the Gram negative bacteria were isolated from the sputum of diabetic patients.
We found different groups of bacteria have predilection for causing CAP in two different groups of patients. DM has been associated with many alteration of the immune system. There is significant changes within humoral and cell mediated immunity, particularly related to the neutrophil function, pulmonary function abnormality such as reduction of diffusion capacity in diabetic patients having signs of microangiopathy 19 . In relation to pulmonary infection, the few available studies suggest this alteration of immune system in diabetic patients but do not prove certain association between DM and susceptibility by uncommon microorganism 20,21 .
Our study disclosed sensitivity pattern of isolated strain of bacteria from diabetic and non-diabetic CAP patients. It is alarming that resistant bacteria are emerging from both groups of patients, specially the strain isolated from the sputum of diabetic patients. It was observed that isolated Klebsiella pneumonia strain from diabetic patients was mostly resistant to commonly used antibiotics for CAP. Other isolated organisms like Staphylococcus aureus, Pseudomonas aeruginosa, E.coli from diabetic patients with CAP were also resistant to -lactamase inhibitor, Macrolides and third generation cephalosporin.
Streptococcus pneumoniae mostly isolated from non-diabetic patients were sensitive to commonly used antibiotics for CAP. Our study also revealed We evaluated the immediate outcome of CAP patients between diabetic and non-diabetic. Immediate outcome was assessed on the basis of duration of hospital stay, improvement, transfer to ICU or other institution, surgical intervention and other complications like empyema, abscess formation and mortality outcome. It was observed that hospital duration, ICU transfer and development of complications were significantly higher in diabetic patients than that of nondiabetics. On the other hand improvement during hospital discharge in non diabetic with CAP is more in comparison with Diabetic. Pneumonia severity scoring was done (CURB-65) in all patients and significantly higher scoring was found in diabetic patients.
In conclusion, clinical presentation, microbial characteristics, antimicrobial susceptibility and immediate outcome of CAP differed in diabetics and non-diabetics. Frequency of atypical presentation and CURB-65 score were significantly higher in diabetics. Klebsiella pneumoniae was the most frequent causative pathogen for CAP in diabetic patients, whereas Streptococcus pneumoniae was the most frequent causative agent for non-diabetic patients. Bacteria isolated from sputum sample of CAP with diabetes were resistant to almost all recommended antibiotics used for CAP but 100% isolates were sensitive to Carbapenems. Pulmonary complications were relatively more in diabetics and they required referral to intensive care unit more than that of nondiabetics. So, diabetic patients with CAP require extra attention.
